13 Feb [141] Paxlovid in British Columbia – Interim real-world analysis
Nirmatrelvir and ritonavir (NMV-r; PaxlovidTM) is an oral antiviral drug combination that targets a key SARS-CoV-2 protease enzyme. It was approved by Health Canada on January 17, 2022 for treatment of mild-to-moderate Covid-19 disease in...